Forian Inc Faces Financial Challenges as Company Slips into the Red2.

Remembering the Legacy of Director Martin J. Wygod at Forian Inc

Published / Modified May 15 2024
Goran Soko / CSIMarket.com

Heartbreak for Forian Inc.
as Director Martin J.
Wygod Passes Away at 84

Forian Inc., a leading provider of data science-driven information and analytics solutions to the healthcare and life sciences industries, is in mourning after the passing of its esteemed director, Martin J.
Known as Marty, Wygod was a renowned healthcare entrepreneur, thoroughbred horse breeder, and philanthropist, leaving behind a legacy that will forever be remembered in the industry.
His sudden departure has come as a great shock to the Forian family, particularly to his son, Max Wygod, who serves as Forian's Executive Chairman, Chief Executive Officer, and President.

Throughout his career, Wygod epitomized the spirit of innovation and foresight, bringing transformational advancements to the healthcare sector.
With his visionary approach, he revolutionized the field, earning widespread respect and admiration from his peers.
He was not just a director at Forian; he was the driving force behind the company's dedication to leveraging data science and analytics to improve healthcare outcomes.

While mourning the loss of their respected director, Forian Inc.
faces financial challenges in the first quarter of 2024.
During this period, the company slipped into a shortfall of $-0.04 per share, compared to $0.19 from a year ago.
Income per share also fell from $0.04 to -$0.04 from the previous reporting season.
Although the revenue grew moderately by 0.144% to $4.88 million from $4.87 million in the same period last year, it deteriorated by -9.156% sequentially, from $5.37 million.
However, in comparison to the Cloud Computing & Data Analytics sector peers, Forian Inc.
achieved a respectable 5.91% relative top-line improvement.

The market and stock performance of Forian Inc.
has seen some ups and downs recently.
The stock has improved by 8.71% from a year ago, bringing the share price to -1.87% in the past 90 days.
Currently trading on the NASDAQ, its stock is approximately -0% below its 52-week average.

As Forian Inc.
navigates these financial challenges and mourns the loss of its esteemed director, Martin J.
Wygod, the company remains dedicated to carrying forward his legacy.
With his visionary leadership and dedication to leveraging data science and analytics, Forian Inc.
will strive to improve healthcare outcomes and continue driving innovation in the industry.

Forian Inc's Operating Margin

Forian Inc's Price to Book ratio


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com